NCS Health Limited

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Peter Cowen COO Officer
Transaction date
Sale
Price
265.38
Quantity 1,842
Value £4,215,239
Damian Coley Chief Legal Officer Officer
Transaction date
Sale
Price
226.46
Quantity 603
Value £2,019,809
Patrick Meehan CFO Officer
Transaction date
Sale
Price
341.24
Quantity 23,600
Value £2,258,342
Laura Wilson CEO Officer
Transaction date
Sale
Price
2.68
Quantity 12,524
Value £33,564
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-01-27 2024-05-15 S Sale Peter Cowen

COO

Officer
1,842
265.38
£4,215,239
1,842 265.38 £4,215,239
2026-01-27 2024-05-15 S Sale Damian Coley

Chief Legal Officer

Officer
603
226.46
£2,019,809
603 226.46 £2,019,809
2026-01-27 2024-05-15 S Sale Patrick Meehan

CFO

Officer
23,600
341.24
£2,258,342
23,600 341.24 £2,258,342
2026-01-27 2024-05-15 S Sale Laura Wilson

CEO

Officer
12,524
2.68
£33,564
12,524 2.68 £33,564
Explore more

More insider trading research around NCS Health Limited